key: cord-0892766-mhsllkg4 authors: Gilad, Vered; De Marzo, Vincenzo; Guglielmi, Giulia; Bona, Roberta Della; Giovinazzo, Stefano; Pescetelli, Fabio; Valbusa, Alberto; Bezante, Gian Paolo; De Maria, Andrea; Patroniti, Nicolò; Ferone, Diego; Pelosi, Paolo; Bassetti, Matteo; Porto, Italo title: Cardiac point-of-care ultrasound in hospitalized coronavirus disease-2019 patients: findings and association with outcome date: 2021-10-22 journal: J Cardiovasc Med (Hagerstown) DOI: 10.2459/jcm.0000000000001177 sha: b2c7f1612b5736641be33414b0edd7632bb5d189 doc_id: 892766 cord_uid: mhsllkg4 nan Given consistent limitations and risks for echocardiography in COVID-19, both American and European echocardiography societies released recommendations to limit systematic echocardiography examination to problem-tailored and time-limited examination, also known as 'point-of-care ultrasound' (POCUS). 6, 7 We aimed to describe cardiac POCUS findings in COVID-19 patients admitted to a tertiary Italian university hospital, stratified according to respiratory distress grade, and to assess the association of cardiac POCUS findings with outcome. All laboratory-confirmed COVID-19 patients admitted to our hospital, San Martino Hospital, Genoa, Italy, between 1 March 2020 and 30 April 2020 who underwent cardiac POCUS during hospital stay were analysed. According to the respiratory distress degree, 8 patients were classified into mild, moderate, and severe respiratory distress grade. All methods were extensively described in Supplemental Digital Content S1, http://links.lww.com/JCM/A366. The final population included 138 patients. Table 1 depicts the patients' characteristics and findings. POCUS findings are described in Fig. 1 , and outcomes are described in Fig. 2 , both stratified according to respiratory distress grade at time of POCUS execution. At multivariate logistic regression analysis, left ventricular (LV) hypertrophy (P ¼ 0.030) was significantly associated with severe respiratory distress and right ventricular (RV) dilatation (P ¼ 0.036) was significantly associated with longer in-hospital stay. No cardiac POCUS parameter was associated with cardiovascular outcomes (all P > 0.05) ( Table 2) . Our study has the following main findings: most common cardiac POCUS abnormalities in COVID-19 patients were LV hypertrophy, mild pericardial effusion and RV dilatation, with LV and RV systolic functions mostly preserved; LV hypertrophy was independently associated with severe respiratory distress; RV dilatation was independently associated with longer hospital stay; no cardiac POCUS parameter was associated with inhospital mortality. Arterial hypertension, highly prevalent within our cohort (53.6%), is the most common cause for LV hypertrophy. 9 Hypertensive heart disease is characterized by cardiac fibrosis, increased myocardial stiffness, microvascular dysfunction, abnormal ventricular-vascular interactions and progressive diastolic dysfunction. 10 Diastolic dysfunction was demonstrated as a major predictor of mortality in patients with sepsis and septic shock, 11 and recent reports showed a higher degree of diastolic dysfunction associated with poorer prognosis in COVID-19 patients. 12, 13 Multiple extracardiac mechanisms may induce RV dilatation in COVID-19 patients: extensive lung damage, hypoxic vasoconstriction, excessive positive end-expiratory pressure, high-pressure mechanical ventilation, pulmonary vascular diseases, and pulmonary embolism. Whereas RV dilatation was a common finding, RV dysfunction was infrequent (5.1%) in our cohort. Although our results are in contrast to previous reports, conventional RV functional parameters (TAPSE, Tei index and Cardiac POCUS in hospitalized COVID-19 patients Gilad et al. e5 Szekely et al. 13 and Li et al., 14 for which RV dysfunction was determined by short pulmonary acceleration time and reduced RV strain, respectively. These results suggest that RV dysfunction in COVID-19 patients is generally modest and that conventional RV function parameters may be insufficient for risk stratification in this population. Left ventricle dysfunction was uncommon (13%) and the vast majority of patients had only mild LV dysfunction (66.6%), similar to D'Andrea et al.'s 15 findings. Moreover, whereas myocardial injury was frequent and independently associated with in-hospital mortality, most patients had minimal troponin I increase. Limitations to our study are principally related to the particular situation in which we were operating: the retrospective design, the potential selection bias as only selected COVID-19 patients underwent cardiac POCUS, the lack of prior echocardiographic data for comparison, the lack of systematic diastole assessment, the small sample size, and the large confidence intervals of the estimates. World Health Organization. Coronavirus pandemic declaration A novel coronavirus outbreak of global health concern COVID-19 and cardiovascular disease Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel Development of a COVID-19 point-of-care ultrasound protocol Respiratory distress syndrome Renin-angiotensinaldosterone system blockers and the risk of covid-19 From left ventricular hypertrophy to dysfunction and failure Diastolic dysfunction and mortality in severe sepsis and septic shock Characterization of myocardial injury in patients with COVID-19 The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19) -a systematic echocardiographic study The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19 Right ventricular function and pulmonary pressures as independent predictors of survival in patients with COVID-19 pneumonia Acknowledgements There are no conflicts of interest.